Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

This study has been completed.
Information provided by:
Valeant Pharmaceuticals International, Inc. Identifier:
First received: December 22, 2005
Last updated: December 21, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)